Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences

April 12, 2001

Inderide LA Capsules Recalled by Wyeth Pharmaceuticals

Guayama, Puerto Rico (SafetyAlerts) - The Food and Drug Administration (FDA) said today that Wyeth Pharmaceuticals Company has recalled certain Inderide LA 160 mg/50 mg caps because of dissolution failure for Hydrochlorothiazide component.

This is the first public notice of this Class III recall issued by FDA.

Inderide LA 160 mg/50 mg caps (Propranolol HCL 160 mg/Hydrochlorothiazdie 50 mg), NDC 0046-0459-81, bottles of 100 caps. 24 bottles of 100's per shipper.

Recall #D-163-1.

Lot no. 999041 exp. date 7/01.

Wyeth Pharmaceuticals Company, Guayama, PR.

Manufacturer, by letters dated 2/28/01. Firm-initiated recall ongoing.


5, 576 bottles of 100.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.

Notice of this product warning was sent via email to SafetyAlerts subscribers April 12, 2001.  For more information regarding the SafetyAlerts free email alert service please click here.

Selected Recent Recalls

Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.


The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.